Comment on "Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease"

Pauwels, R.W.M. (Renske W M), de Vries, A.C. (Annemarie C.) and van der Woude, C.J. (C Janneke)

2019-04-11

Inflammatory Bowel Diseases , Volume 25 - Issue 5 p. e59

Additional Metadata
Persistent URL	doi.org/10.1093/ibd/izy273, hdl.handle.net/1765/117974
Journal	Inflammatory Bowel Diseases
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Pauwels, R.W.M. (Renske W M), de Vries, A.C. (Annemarie C.), & van der Woude, C.J. (C Janneke). (2019). Comment on "Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease". Inflammatory Bowel Diseases, 25(5). doi:10.1093/ibd/izy273

Publication